214 related articles for article (PubMed ID: 34614512)
21. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.
Hong SY; Hagen T
Biochem Biophys Res Commun; 2015 Oct; 465(4):838-44. PubMed ID: 26315267
[TBL] [Abstract][Full Text] [Related]
22. miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors.
Bacci M; Giannoni E; Fearns A; Ribas R; Gao Q; Taddei ML; Pintus G; Dowsett M; Isacke CM; Martin LA; Chiarugi P; Morandi A
Cancer Res; 2016 Mar; 76(6):1615-26. PubMed ID: 26795347
[TBL] [Abstract][Full Text] [Related]
23. Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer.
Fan P; Jordan VC
Target Oncol; 2022 Mar; 17(2):111-124. PubMed ID: 35290592
[TBL] [Abstract][Full Text] [Related]
24. Unfolded protein response is involved in geniposide-regulating glucose-stimulated insulin secretion in INS-1 cells.
Hao Y; Shen S; Yin F; Zhang Y; Liu J
Cell Biochem Funct; 2019 Jul; 37(5):368-376. PubMed ID: 31215684
[TBL] [Abstract][Full Text] [Related]
25. Effects of muscular dystrophy, exercise and blocking activin receptor IIB ligands on the unfolded protein response and oxidative stress.
Hulmi JJ; Hentilä J; DeRuisseau KC; Oliveira BM; Papaioannou KG; Autio R; Kujala UM; Ritvos O; Kainulainen H; Korkmaz A; Atalay M
Free Radic Biol Med; 2016 Oct; 99():308-322. PubMed ID: 27554968
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.
Sato A; Takagi K; Miki Y; Yoshimura A; Hara M; Ishida T; Sasano H; Suzuki T
Histol Histopathol; 2019 Dec; 34(12):1365-1375. PubMed ID: 31149728
[TBL] [Abstract][Full Text] [Related]
27. Prodigiosin activates endoplasmic reticulum stress cell death pathway in human breast carcinoma cell lines.
Pan MY; Shen YC; Lu CH; Yang SY; Ho TF; Peng YT; Chang CC
Toxicol Appl Pharmacol; 2012 Dec; 265(3):325-34. PubMed ID: 22982536
[TBL] [Abstract][Full Text] [Related]
28. Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.
Weigel MT; Ghazoui Z; Dunbier A; Pancholi S; Dowsett M; Martin LA
Breast Cancer Res; 2012 May; 14(3):R78. PubMed ID: 22608253
[TBL] [Abstract][Full Text] [Related]
29. Connecting endoplasmic reticulum stress to autophagy through IRE1/JNK/beclin-1 in breast cancer cells.
Cheng X; Liu H; Jiang CC; Fang L; Chen C; Zhang XD; Jiang ZW
Int J Mol Med; 2014 Sep; 34(3):772-81. PubMed ID: 24970676
[TBL] [Abstract][Full Text] [Related]
30. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
[TBL] [Abstract][Full Text] [Related]
31. The IRE1 and PERK arms of the unfolded protein response promote survival of rhabdomyosarcoma cells.
McCarthy N; Dolgikh N; Logue S; Patterson JB; Zeng Q; Gorman AM; Samali A; Fulda S
Cancer Lett; 2020 Oct; 490():76-88. PubMed ID: 32679165
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor mediates a distinct mitochondrial unfolded protein response.
Papa L; Germain D
J Cell Sci; 2011 May; 124(Pt 9):1396-402. PubMed ID: 21486948
[TBL] [Abstract][Full Text] [Related]
33. Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells.
Garrido P; Osorio FG; Morán J; Cabello E; Alonso A; Freije JM; González C
J Cell Physiol; 2015 Jan; 230(1):191-8. PubMed ID: 24931902
[TBL] [Abstract][Full Text] [Related]
34. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
35. Identification of signaling pathways modulated by RHBDD2 in breast cancer cells: a link to the unfolded protein response.
Lacunza E; Rabassa ME; Canzoneri R; Pellon-Maison M; Croce MV; Aldaz CM; Abba MC
Cell Stress Chaperones; 2014 May; 19(3):379-88. PubMed ID: 24078384
[TBL] [Abstract][Full Text] [Related]
36. Estrogen signaling and unfolded protein response in breast cancer.
Rajapaksa G; Thomas C; Gustafsson JÅ
J Steroid Biochem Mol Biol; 2016 Oct; 163():45-50. PubMed ID: 27045680
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway.
Hsu HP; Chu PY; Chang TM; Huang KW; Hung WC; Jiang SS; Lin HY; Tsai HJ
Cancer Med; 2023 Jan; 12(2):1588-1601. PubMed ID: 35757841
[TBL] [Abstract][Full Text] [Related]
38. Novel prosurvival function of Yip1A in human cervical cancer cells: constitutive activation of the IRE1 and PERK pathways of the unfolded protein response.
Taguchi Y; Horiuchi Y; Kano F; Murata M
Cell Death Dis; 2017 Mar; 8(3):e2718. PubMed ID: 28358375
[TBL] [Abstract][Full Text] [Related]
39. Herpes Simplex Virus 1 UL41 Protein Suppresses the IRE1/XBP1 Signal Pathway of the Unfolded Protein Response via Its RNase Activity.
Zhang P; Su C; Jiang Z; Zheng C
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928013
[TBL] [Abstract][Full Text] [Related]
40. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
